Catalyst Wire Dossier Catalyst Wire Dossier

LFG316

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for LFG316, covering 2012-05-01 to 2024-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria [Phase 2]

See pricing